Johnson & Johnson's Board of Directors Approves $10 Billion Stock Buyback Program

NEW YORK — Johnson & Johnson said Tuesday that its board of directors approved a $10 billion stock buyback plan. The health care and pharmaceutical products company said there is no time limit on the program and it will be financed through the issuance of debt...
Login to comment.